Active Trending Stocks: T-Mobile US, Inc. (NYSE:TMUS), Pfizer Inc. (NYSE:PFE), DDR Corp. (NYSE:DDR)

On Thursday, Shares of T-Mobile US, Inc. (NYSE:TMUS), lost -1.10% to $38.62.
In the latest in its series of Un-carrier Amped declarations, T-Mobile US, again took direct aim at the carriers’ shared data schemes and punitive overages. Recently, T-Mobile unveiled yet another industry-rocking move, serving up 10GB of 4G LTE for each and every data-hungry family member at an unprecedented price.



With the new offer, two people can get up to 10 GB of 4G LTE data each – no sharing required – for just $100 a month. Then, each additional line is just $20 more per person – also with 10 GB of T-Mobile’s blazing-fast 4G LTE. As always,
 every line comprises unlimited data, talk and text in addition to all the Un-carrier™ benefits like no annual service contracts, no overages, data and texting when traveling internationally in over 120 countries at no extra charge, Music Freedom, Wi-Fi calling and texting, Data Stash™, and − as of just last week − calling and coverage to and from the U.S., plus Mexico & Canada comprised of at no extra cost.

T-Mobile US, Inc., together with its auxiliaries, provides mobile communications services in the United States, Puerto Rico, and the U.S. Virgin Islands. The company offers voice, messaging, and data services in the postpaid, prepaid, and wholesale markets.

Shares of Pfizer Inc. (NYSE:PFE), inclined 0.34% to $35.10, during its last trading session.
Pfizer, declared recently enrollment of the first patient in a Phase 2b clinical trial of its investigational Staphylococcus aureus (S. aureus) multi-antigen vaccine (PF-06290510) in adults undergoing elective spinal fusion surgery. The purpose of the study, named STRIVE (STaphylococcus aureus SuRgical Inpatient Vaccine Efficacy), is to evaluate the safety and efficacy of the vaccine to determine if it prevents postoperative invasive S. aureus infections in patients undergoing elective spinal surgery.
Surgical Site Infections (SSIs) are a noteworthyand growing concern. SSIs caused by S. aureus account for about 20 percent of all SSIs in the U.S., and are associated with an estimated annual treatment cost of $12.3 billion in the U.S., Patients who suffer such infections due to antibiotic resistant (MRSA) or antibiotic sensitive (MSSA) S.aureus have worse clinical outcomes, counting raised mortality in comparison with non-infected patients.
“We are happy to take this important next step in the development of our S. aureus vaccine,” said Dr. Kathrin Jansen, senior vice president and chief scientific officer of Vaccine Research and Development for Pfizer. “To date, there is no licensed vaccine accessible to prevent invasive S. aureus disease. We believe results from this study, if positive, will bring us closer to a potential preventive measure for this challenging disease that is associated with considerable morbidity and mortality.”
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Finally, DDR Corp. (NYSE:DDR), ended its last trade with 2.02% gain, and closed at $16.19.
On July 1, DDR Corp., declared that it closed on the acquisition of two power centers and an adjoining outparcel valued at $111 million and the disposition of ten assets totaling $102 million at 100% ownership during the second quarter of 2015.

The Company attained Willowbrook Plaza, a 385,000-square-foot power center located in Houston, Texas. The asset is adjacent to Willowbrook Mall, one of Houston’s top performing malls, and presents noteworthy opportunity to drive occupancy and NOI growth given its current 87% leased rate. The asset also has the potential for at least 10,000 square feet of expansion. DDR also attained International Drive Value Center, a 186,000-square-foot power center located in Orlando, Florida. The center’s tenant lineup features a strong mix of national retailers, counting two of the highest-performing Ross Dress for Less and T.J. Maxx stores in each respective chain. The asset is located in a submarket with two of the nation’s most productive retail properties, the Mall at Millenia and Orlando International Premium Outlets. Year-to-date, the Company has attained $160 million of assets at DDR’s share.
During the second quarter, DDR also sold seven operating assets and three land parcels for an aggregate $60 million at the Company’s share. DDR has an additional 18 operating assets and three land parcels under contract for sale, representing an predictable total value of $119 million at the Company’s share. Year-to-date, the Company has sold $213 million of assets at DDR’s share.
DDR Corp. is an equity real estate investment trust. It invests in the real estate markets of the United States and Puerto Rico. The firm is in the business of acquiring, owning, developing, redeveloping, expanding, leasing and managing shopping centers. It formerly known as Developers Diversified Realty Corp. DDR Corp is based in Beachwood, Ohio.


DISCLAIMER:
 All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.